<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) holds the third highest incidence and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related mortality rate among men and women in the United States </plain></SENT>
<SENT sid="1" pm="."><plain>Unfortunately, there has been little progression made in the treatment of this deadly disease once it has spread beyond the colon </plain></SENT>
<SENT sid="2" pm="."><plain>It has been hypothesize that <z:hpo ids='HP_0003003'>colon cancer</z:hpo> stem cells are implicated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and therapeutic resistance </plain></SENT>
<SENT sid="3" pm="."><plain>One of the difficulties in testing these hypotheses is the current use of established high-passage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>Long term, high-passage established cell lines have cells with stem like properties as they propagate almost indefinitely </plain></SENT>
<SENT sid="5" pm="."><plain>These cells are thought to be different than the original <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells in fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In order to investigate <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells, and molecularly profiling <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with high fidelity to the original <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>, one needs to establish suitable primary ultra-low passage cell lines from fresh surgical specimens </plain></SENT>
<SENT sid="7" pm="."><plain>Here we report the establishment of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> initiating <z:hpo ids='HP_0003003'>colon cancer</z:hpo> ultra-low passage cell lines by a combination of gentle mechanical, enzymatic dissociation, spheroid formation, and followed by two generation xenografts from fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> obtained at time of operation </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> generated were characterized by <z:mp ids='MP_0000002'>morphology</z:mp>, flow cytometry, immunofluorescence, and by gene expression </plain></SENT>
<SENT sid="9" pm="."><plain>In the future, such a technology can be used to produce expeditiously enough material to test for mutations, genetic signatures and molecular subtyping readily available for clinical therapeutic decision making </plain></SENT>
</text></document>